Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
June 21, 2022
Patent Application Number
16944008
Date Filed
July 30, 2020
Patent Citations
Patent Primary Examiner
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. The capsule fill can include a solubilizer and about 14 wt % to about 35 wt % testosterone undecanoate based on the total capsule fill. The oral dosage capsule is such that when a single oral administration to a male subject of one or more capsules with a total testosterone undecanoate daily dose of about 350 mg to about 650 mg it provides a ratio of serum testosterone C
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.